Abstract Library

#1272 Telotristat Etiprate Appears to Halt Carcinoid Heart Disease

Introduction: Carcinoid Heart Disease (CHD) is a serious complication of the Carcinoid Syndrome (in as many as 50% of patients during the course of their disease). 46% of cases operated with bioprosthetic valves develop recurrent carcinoid valvulopathy on the newly implanted tissue valves. Until now, only mechanical prosthetic valves avoid recurrent fibrosis.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Zacks J

Authors: Zacks J, Lavine R, Ratner L, Warner R,

Keywords: carcinoid heart disease, valve, heart failure, carcinoid syndrome, prosthetic valves, telotristat etiprate,

#230 Long-term Follow-up of Tissue Valve Prostheses in Carcinoid Heart Disease

Introduction: Development of carcinoid heart disease (CHD) increases morbidity and mortality. Cardiac valve replacement surgery improves functional class, but tissue prosthesis degeneration can occur early in CHD.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Knight D, Bhattacharyya S, Toumpanakis C, Caplin M, Davar J,

Keywords: carcinoid heart disease, bioprosthetic valves, 5-HIAA, chromogranin A, pulmonary homograft stenosis,